139 related articles for article (PubMed ID: 32111468)
1. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms.
Çelebi F; Yaghouti K; Cindil E; Dogusoy GB; Tokat Y; Balcı C
Acad Radiol; 2021 Feb; 28(2):189-198. PubMed ID: 32111468
[TBL] [Abstract][Full Text] [Related]
2. 18 F-FDG PET/MRI of Primary Hepatic Malignancies: Differential Diagnosis and Histologic Grading.
Sokmen BK; Inan N
Curr Med Imaging; 2024; 20():e080523216636. PubMed ID: 37157218
[TBL] [Abstract][Full Text] [Related]
3. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
Song JY; Lee YN; Kim YS; Kim SG; Jin SJ; Park JM; Choi GS; Chung JC; Lee MH; Cho YH; Choi MH; Kim DC; Choi HJ; Moon JH; Lee SH; Jeong SW; Jang JY; Kim HS; Kim BS
Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069
[TBL] [Abstract][Full Text] [Related]
4. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
[TBL] [Abstract][Full Text] [Related]
5. Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
Jiang L; Tan H; Panje CM; Yu H; Xiu Y; Shi H
Clin Nucl Med; 2016 Jan; 41(1):1-7. PubMed ID: 26402131
[TBL] [Abstract][Full Text] [Related]
6. Comparison of PET imaging of activated fibroblasts and
Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
[TBL] [Abstract][Full Text] [Related]
7. The value of 18F-FDG PET/MRI in prediction of microvascular invasion in hepatocellular carcinoma.
Çelebi F; Görmez A; Ilgun AS; Tokat Y; Balcı NC
Eur J Radiol; 2022 Apr; 149():110196. PubMed ID: 35144118
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
9. Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.
Boussouar S; Itti E; Lin SJ; Decaens T; Evangelista E; Chiaradia M; Chalaye J; Baranes L; Calderaro J; Laurent A; Pigneur F; Duvoux C; Azoulay D; Costentin C; Rahmouni A; Luciani A
Cancer Imaging; 2016 Feb; 16():4. PubMed ID: 26883745
[TBL] [Abstract][Full Text] [Related]
10. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
[TBL] [Abstract][Full Text] [Related]
11. Quantitative parameters derived from
Meng Z; Zhang L; Huang C; Piao Y; Chen X; Xian J
Neuroradiology; 2022 Nov; 64(11):2153-2162. PubMed ID: 36121469
[TBL] [Abstract][Full Text] [Related]
12. Dynamic
Wang J; Shao Y; Liu B; Wang X; Geist BK; Li X; Li F; Zhao H; Hacker M; Ding H; Zhang H; Huo L
BMC Med Imaging; 2021 May; 21(1):90. PubMed ID: 34034664
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of pretreatment SUV in 18F-FDG/PET in breast cancer: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
Baba S; Isoda T; Maruoka Y; Kitamura Y; Sasaki M; Yoshida T; Honda H
J Nucl Med; 2014 May; 55(5):736-42. PubMed ID: 24665089
[TBL] [Abstract][Full Text] [Related]
15. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
Yamamoto Y; Nishiyama Y; Kameyama R; Okano K; Kashiwagi H; Deguchi A; Kaji M; Ohkawa M
J Nucl Med; 2008 Aug; 49(8):1245-8. PubMed ID: 18632827
[TBL] [Abstract][Full Text] [Related]
16. Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.
Lee JY; Kim HJ; Yim SH; Shin DS; Yu JH; Ju DY; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2013 Oct; 62(4):227-33. PubMed ID: 24162710
[TBL] [Abstract][Full Text] [Related]
17. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.
Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Mori A; Doi R; Ikai I; Uemoto S
Surgery; 2008 Jun; 143(6):769-77. PubMed ID: 18549893
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Metabolic Parameters of 18F-FDG PET/CT and Apparent Diffusion Coefficient of MRI in Hepatocellular Carcinoma.
Hong CM; Ahn BC; Jang YJ; Jeong SY; Lee SW; Lee J
Clin Nucl Med; 2017 Feb; 42(2):95-99. PubMed ID: 27941378
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI and
Chung YH; Yu CF; Chiu SC; Chiu H; Hsu ST; Wu CR; Yang CL; Hong JH; Yen TC; Chen FH
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1733-1744. PubMed ID: 31127350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
